Glaxo SmithKline
Last Updated:
- 27.75 EGP
- 0.01
- 0.04%
جلاكسو سميثكلاين
جلاكسو سميثكلاين
Symbol :
BIOC
ISIN :
EGS38171C012
52-Week Range :
26.26
-
47.50
Turnover Ratio :
0.16
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Top News
- A 01-June GSK Egypt generates lower consolidated profits in Q1-23
- B 01-June GSK Egypt generates lower consolidated profits in Q1-23
- C 04-May GSK Egypt’s shareholders approve 2022 cash dividends
- D 04-May GSK Egypt’s shareholders approve 2022 cash dividends
- E 03-April GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
- F 03-April GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
- G 30-November GSK Egypt sees surge in 9M-22 consolidated profits
- H 30-November GSK Egypt sees surge in 9M-22 consolidated profits
- I 17-November GSK Egypt posts higher standalone profits at EGP 930m in 9M-22
- J 31-August GSK Egypt’s profits climb to EGP 872m in H1-22
- K 14-June GSK Egypt's consolidated profits skyrocket in Q1-22
- L 01-June GSK Egypt's standalone profits hike in Q1-22
